Clinical Trial Update: Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial compares an ultra-short course regimen of bedaquiline, clofazimine, pyrazinamide, and delamanid against standard therapy for drug-su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Pulmonary Tuberculosis
• Tuberculosis

Drugs mentioned

• Deltyba (delamanid)
• Lamprene (clofazimine)
• Pyrazinamide (pyrazinamide)
• SIRTURO (bedaquiline fumarate)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Tuberculosis, Pulmonary, HIV | Phase 2 | Status: ACTIVE_NOT_RECRUITING